Published in Am J Gastroenterol on January 14, 2014
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22
Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29
The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med (2014) 0.97
Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers. Cancer Med (2016) 0.79
Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78
Proton Pump Inhibitors: The Culprit for Barrett's Esophagus? Front Oncol (2015) 0.77
Risk Factors for Barrett's Oesophagus. Gastrointest Tumors (2016) 0.75
Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One (2016) 0.75
Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One (2016) 0.75
The epidemiology, diagnosis, and treatment of Barrett's carcinoma. Dtsch Arztebl Int (2015) 0.75
Barrett esophagus: history, definition and etiopathogeny. J Med Life (2014) 0.75
Adenocarcinoma of Barrett's esophagus in a dog. J Toxicol Pathol (2017) 0.75
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28
Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol (1995) 9.98
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) (2008) 3.97
Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol (2002) 3.94
The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology (1991) 3.38
Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg (1975) 2.92
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan. Am J Gastroenterol (2004) 2.14
Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ (2003) 2.04
Opposing time trends of peptic ulcer and reflux disease. Gut (1998) 1.99
Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90
The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter (2012) 1.74
The gastric precancerous cascade. J Dig Dis (2012) 1.70
Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies. Aliment Pharmacol Ther (1996) 1.68
H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter (1998) 1.52
Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol (2007) 1.49
Use of adjustment factors with a brief food frequency questionnaire to obtain nutrient values. Epidemiology (1990) 1.47
Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol (2013) 1.09
Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells. J Biol Chem (2008) 1.04
Retracted Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.03
Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol (2009) 0.99
Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials. Scand J Gastroenterol (2012) 0.99
Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus (2009) 0.95
Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study. Eur J Cardiothorac Surg (1993) 0.88
Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol (2010) 0.86
Histopathologic study on development and extension of atrophic change in the gastric mucosa. Gastroenterol Jpn (1984) 0.78